Department of Ophthalmology, University of Kitasato School of Medicine, Kanagawa, Japan.
J Cataract Refract Surg. 2010 Jan;36(1):164-6. doi: 10.1016/j.jcrs.2009.08.021.
We report a case in which toric intraocular Collamer lenses (ICLs) effectively corrected the refractive errors of pellucid marginal degeneration (PMD). Preoperatively, in the patient's right eye, the manifest refraction was -10.5 -3.5 x 55, the uncorrected distance visual acuity (UDVA) was 20/1000, and the corrected distance visual acuity (CDVA) was 20/16; in the left eye, the manifest refraction was -11.0 - 6.5 x 130 and the UDVA and CDVA were 20/1000 and 20/20, respectively. After bilateral implantation of a toric ICL, in the right eye, the manifest refraction was +1.50 - 0.75 x 10, the UDVA was 20/16, and the CDVA was 20/12.5; in the left eye, the manifest refraction was +2.5 -3.25 x 125 and the UDVA and CDVA were 20/40 and 20/16, respectively. No sign of progressive disease and no vision-threatening complication were observed during the 6-month follow-up. Toric ICL implantation may be a viable surgical option for the correction of high myopic astigmatism in eyes with PMD.
No author has a financial or proprietary interest in any material or method mentioned. Additional disclosures are found in the footnotes.
我们报告了一个病例,其中 toric 人工晶状体(ICL)有效地矫正了透明边缘变性(PMD)的屈光不正。术前,患者右眼的显 微屈光度为-10.5-3.5 x 55,未矫正的远距视力(UDVA)为 20/1000,矫正的远距视力(CDVA)为 20/16;左眼的显 微屈光度为-11.0-6.5 x 130,UDVA 和 CDVA 分别为 20/1000 和 20/20。双侧植入 toric ICL 后,右眼的显 微屈光度为+1.50-0.75 x 10,UDVA 为 20/16,CDVA 为 20/12.5;左眼的显 微屈光度为+2.5-3.25 x 125,UDVA 和 CDVA 分别为 20/40 和 20/16。在 6 个月的随访中,未观察到疾病进展的迹象和视力威胁的并发症。Toric ICL 植入术可能是矫正 PMD 眼高度近视散光的一种可行手术选择。
没有作者在任何材料或方法中具有财务或专有利益。在脚注中发现了其他披露。